chr7-73571192-C-T
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_012453.4(TBL2):c.875G>A(p.Arg292Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000157 in 1,614,208 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_012453.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TBL2 | NM_012453.4 | c.875G>A | p.Arg292Gln | missense_variant | 6/7 | ENST00000305632.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TBL2 | ENST00000305632.11 | c.875G>A | p.Arg292Gln | missense_variant | 6/7 | 1 | NM_012453.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152248Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000159 AC: 40AN: 251108Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135788
GnomAD4 exome AF: 0.000160 AC: 234AN: 1461842Hom.: 1 Cov.: 32 AF XY: 0.000158 AC XY: 115AN XY: 727218
GnomAD4 genome AF: 0.000125 AC: 19AN: 152366Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 05, 2023 | The c.875G>A (p.R292Q) alteration is located in exon 6 (coding exon 6) of the TBL2 gene. This alteration results from a G to A substitution at nucleotide position 875, causing the arginine (R) at amino acid position 292 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2022 | TBL2: BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at